Liver Dysfunction as a Novel Player in Alzheimer’s Progression: Looking Outside the Brain
Alzheimer’s disease (AD) afflicts an estimated 20 million people worldwide and is the fourth-leading cause of death in the developed world. The most common cause of dementia in older individuals, AD is characterized by neuropathologies including synaptic and neuronal degeneration, amyloid plaques, a...
Main Authors: | Lisbell D. Estrada, Pablo Ahumada, Daniel Cabrera, Juan P. Arab |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2019.00174/full |
Similar Items
-
Editorial on, Amyloid-beta clearance in Alzheimer’s disease.
by: Robert eMarr
Published: (2014-11-01) -
Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
by: Xue-Mei Qi, et al.
Published: (2018-01-01) -
The neuronal membrane as a key factor in neurodegeneration.
by: Raquel eMarin
Published: (2013-07-01) -
Albumin Exchange in Alzheimer's Disease: Might CSF Be an Alternative Route to Plasma?
by: Manuel Menendez-Gonzalez, et al.
Published: (2019-10-01) -
BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)